The global Embolic Protection Devices Market is predicted to grow at an annual growth rate of 8.3 per cent during the forecast period and it is estimated to reach $604.9 million by 2023 according to a new report by MarketsandMarkets Research Private Ltd. North America dominated the market in 2017, and APAC is expected to grow at the highest annual rate.
On the basis of application, the market is categorized into cardiovascular, neurovascular, and peripheral vascular diseases. The neurovascular segment is expected to grow at the highest CAGR during the forecast period.
The favorable medical reimbursement scenarios for neurovascular procedures in developed countries, increasing awareness about the clinical efficacy of embolic protection devices among neurosurgeons, and the rising adoption of these systems across developing countries (such as China and India) are expected to drive the growth of this application segment during the forecast period.
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications.
In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.
The growth of the global market for Embolic Protection Devices is primarily influenced by rising incidence of cardiovascular & neurovascular diseases, funding and investments for R&D on embolic protection devices, technological advancements and rising demand for minimally invasive procedures.
The report can be accessed here
Be First to Comment